|
🐜
|
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
17 auth.
W. Sandborn,
C. Gasink,
Long-Long Gao,
M. Blank,
J. Johanns,
C. Guzzo,
B. Sands,
S. Hanauer,
S. Targan,
P. Rutgeerts,
...
Subrata Ghosh,
W. D. de Villiers,
R. Panaccione,
G. Greenberg,
S. Schreiber,
S. Lichtiger,
B. Feagan
|
10 |
2012 |
10
🐜
|
|
🐜
|
Functional variants of OCTN cation transporter genes are associated with Crohn disease
13 auth.
V. Peltekova,
R. Wintle,
L. Rubin,
C. Amos,
Qiqing Huang,
X. Gu,
B. Newman,
M. V. Oene,
D. Cescon,
G. Greenberg,
...
A. Griffiths,
P. George-Hyslop,
K. Siminovitch
|
9 |
2004 |
9
🐜
|
|
🐜
|
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
31 auth.
J. Rioux,
M. Daly,
M. Silverberg,
K. Lindblad,
H. Steinhart,
Z. Cohen,
T. Delmonte,
Kerry Kocher,
Katie Miller,
Sheila Guschwan,
E. Kulbokas,
Sinead B. O'Leary,
E. Winchester,
K. Dewar,
Todd Green,
...
Valerie Stone,
C. Chow,
A. Cohen,
Diane Langelier,
Gilles Lapointe,
D. Gaudet,
J. Faith,
Nancy Branco,
S. Bull,
R. McLeod,
A. Griffiths,
A. Bitton,
G. Greenberg,
E. Lander,
K. Siminovitch,
T. Hudson
|
9 |
2001 |
9
🐜
|
|
🐜
|
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.
13 auth.
B. Feagan,
G. Greenberg,
G. Wild,
R. Fedorak,
P. Paré,
J. McDonald,
R. Dubé,
A. Cohen,
A. Steinhart,
S. Landau,
...
Rasha A. Aguzzi,
I. Fox,
M. Vandervoort
|
9 |
2005 |
9
🐜
|
|
🐢
|
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
E. Maser,
Renata M Villela,
M. Silverberg,
G. Greenberg
|
9 |
2006 |
9
🐢
|
|
🐢
|
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
C. H. Seow,
A. Newman,
S. Irwin,
A. Steinhart,
M. Silverberg,
G. Greenberg
|
9 |
2009 |
9
🐢
|
|
🐜
|
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.
18 auth.
J. Rioux,
M. Silverberg,
M. J. Daly,
A. Steinhart,
R. McLeod,
A. Griffiths,
Todd Green,
T. Brettin,
Valerie Stone,
S. Bull,
...
A. Bitton,
C. Williams,
G. Greenberg,
Z. Cohen,
E. Lander,
T. Hudson,
T. Hudson,
K. Siminovitch
|
9 |
2000 |
9
🐜
|
|
🦁
|
Oral Budesonide for Active Crohn's Disease
8 auth.
G. Greenberg,
B. Feagan,
F. Martin,
L. Sutherland,
A. Thomson,
C. Williams,
...
L. Nilsson,
T. Persson
|
8 |
1994 |
8
🦁
|
|
🐜
|
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
17 auth.
R. Khanna,
B. Bressler,
B. Levesque,
G. Zou,
L. Stitt,
G. Greenberg,
R. Panaccione,
A. Bitton,
P. Paré,
S. Vermeire,
...
G. D'Haens,
D. Macintosh,
W. Sandborn,
A. Donner,
M. Vandervoort,
J. Morris,
B. Feagan
|
8 |
2015 |
8
🐜
|
|
🐜
|
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
12 auth.
B. Feagan,
R. Fedorak,
E. Irvine,
G. Wild,
L. Sutherland,
A. Steinhart,
...
G. Greenberg,
J. Koval,
Cindy J. Wong,
Marybeth Hopkins,
S. Hanauer,
J. McDonald
|
8 |
2000 |
8
🐜
|
|
🐢
|
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.
21 auth.
B. Feagan,
J. McDonald,
R. Panaccione,
R. Enns,
C. Bernstein,
T. Ponich,
R. Bourdages,
D. Macintosh,
C. Dallaire,
A. Cohen,
...
R. Fedorak,
P. Paré,
A. Bitton,
F. Saibil,
F. Anderson,
A. Donner,
Cindy J. Wong,
G. Zou,
M. Vandervoort,
Marybeth Hopkins,
G. Greenberg
|
8 |
2014 |
8
🐢
|
|
🐜
|
Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin.
13 auth.
B. Feagan,
G. Greenberg,
G. Wild,
R. Fedorak,
P. Paré,
J. McDonald,
A. Cohen,
A. Bitton,
J. Baker,
R. Dubé,
...
S. Landau,
M. Vandervoort,
A. Parikh
|
8 |
2008 |
8
🐜
|
